Spruce Biosciences Announces 2024 Annual Meeting of Stockholders on May 22
Ticker: SPRB · Form: DEF 14A · Filed: Apr 5, 2024 · CIK: 1683553
| Field | Detail |
|---|---|
| Company | Spruce Biosciences, Inc. (SPRB) |
| Form Type | DEF 14A |
| Filed Date | Apr 5, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: Spruce Biosciences, Annual Meeting, Proxy Statement, Director Election, Auditor Ratification
TL;DR
<b>Spruce Biosciences will hold its virtual 2024 Annual Meeting on May 22, 2024, to elect directors and ratify auditor selection.</b>
AI Summary
SPRUCE BIOSCIENCES, INC. (SPRB) filed a Proxy Statement (DEF 14A) with the SEC on April 5, 2024. Spruce Biosciences, Inc. will hold its 2024 Annual Meeting of Stockholders on May 22, 2024, at 9:00 a.m. Pacific Time. The meeting will be conducted virtually via a live webcast at www.virtualshareholdermeeting.com/SPRB2024. Stockholders will vote on the election of two Class I directors for terms until the 2027 annual meeting. The selection of BDO USA, LLP as the independent registered public accounting firm for fiscal year 2024 will be ratified. The record date for determining stockholders entitled to vote is March 25, 2024.
Why It Matters
For investors and stakeholders tracking SPRUCE BIOSCIENCES, INC., this filing contains several important signals. This filing is a definitive proxy statement, indicating the company is proceeding with its annual shareholder meeting and related voting matters. The virtual format for the meeting may impact stockholder engagement and accessibility compared to an in-person event.
Risk Assessment
Risk Level: low — SPRUCE BIOSCIENCES, INC. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational concerns indicated.
Analyst Insight
Stockholders should review the proxy materials to make informed voting decisions on director elections and auditor ratification.
Key Numbers
- May 22, 2024 — Annual Meeting Date (2024 Annual Meeting of Stockholders)
- 9:00 a.m. (Pacific Time) — Annual Meeting Time (2024 Annual Meeting of Stockholders)
- March 25, 2024 — Record Date (Stockholders of record on this date may vote)
- April 5, 2024 — Proxy Material Distribution Date (Proxy materials are being distributed and made available)
Key Players & Entities
- SPRUCE BIOSCIENCES, INC. (company) — Registrant name
- BDO USA, LLP (company) — Independent registered public accounting firm
- May 22, 2024 (date) — Date of Annual Meeting
- March 25, 2024 (date) — Record date for Annual Meeting
- April 5, 2024 (date) — Date proxy materials are distributed
FAQ
When did SPRUCE BIOSCIENCES, INC. file this DEF 14A?
SPRUCE BIOSCIENCES, INC. filed this Proxy Statement (DEF 14A) with the SEC on April 5, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by SPRUCE BIOSCIENCES, INC. (SPRB).
Where can I read the original DEF 14A filing from SPRUCE BIOSCIENCES, INC.?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by SPRUCE BIOSCIENCES, INC..
What are the key takeaways from SPRUCE BIOSCIENCES, INC.'s DEF 14A?
SPRUCE BIOSCIENCES, INC. filed this DEF 14A on April 5, 2024. Key takeaways: Spruce Biosciences, Inc. will hold its 2024 Annual Meeting of Stockholders on May 22, 2024, at 9:00 a.m. Pacific Time.. The meeting will be conducted virtually via a live webcast at www.virtualshareholdermeeting.com/SPRB2024.. Stockholders will vote on the election of two Class I directors for terms until the 2027 annual meeting..
Is SPRUCE BIOSCIENCES, INC. a risky investment based on this filing?
Based on this DEF 14A, SPRUCE BIOSCIENCES, INC. presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational concerns indicated.
What should investors do after reading SPRUCE BIOSCIENCES, INC.'s DEF 14A?
Stockholders should review the proxy materials to make informed voting decisions on director elections and auditor ratification. The overall sentiment from this filing is neutral.
How does SPRUCE BIOSCIENCES, INC. compare to its industry peers?
Spruce Biosciences operates in the pharmaceutical preparations industry, focusing on the development and commercialization of therapies.
Are there regulatory concerns for SPRUCE BIOSCIENCES, INC.?
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, governing proxy solicitations.
Industry Context
Spruce Biosciences operates in the pharmaceutical preparations industry, focusing on the development and commercialization of therapies.
Regulatory Implications
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, governing proxy solicitations.
What Investors Should Do
- Review the proxy statement for details on director nominees.
- Understand the proposal to ratify BDO USA, LLP as the independent auditor.
- Participate in the virtual annual meeting on May 22, 2024, to cast votes.
Key Dates
- 2024-05-22: Annual Meeting of Stockholders — Election of directors and ratification of auditor
- 2024-03-25: Record Date — Determines stockholders eligible to vote
- 2024-04-05: Proxy Material Distribution — Proxy Statement and 2023 Annual Report made available
Year-Over-Year Comparison
This is a DEF 14A filing for the 2024 annual meeting, following the typical schedule for such corporate events.
Filing Stats: 4,755 words · 19 min read · ~16 pages · Grade level 10.8 · Accepted 2024-04-05 16:12:02
Filing Documents
- sprb-def14a-2024.htm (DEF 14A) — 586KB
- img137656660_0.jpg (GRAPHIC) — 2KB
- img137656660_1.jpg (GRAPHIC) — 4KB
- img137656660_2.jpg (GRAPHIC) — 4KB
- img137656660_3.jpg (GRAPHIC) — 85KB
- img137656660_4.jpg (GRAPHIC) — 79KB
- 0000950170-24-042270.txt ( ) — 826KB
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 22
EXECUTIVE COMPENSATION
EXECUTIVE COMPENSATION 27 Director Compensation 34 TRANSACTIONS WITH RELATED PERSONS AND INDEMNIFICATION 36 HOUSEHOLDING OF PROXY MATERIALS 38 OTHER MATTERS 38 i SPRUCE BIOSCIENCES, INC. 611 Gateway Boulevard, Suite 740 South San Francisco, California 94080 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 22, 2024 QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING Why did I receive a notice regarding the availability of proxy materials on the internet? Pursuant to rules adopted by the Securities and Exchange Commission (the “SEC”), we have elected to provide access to our proxy materials over the internet. Accordingly, we have sent you a Notice of Internet Availability of Proxy Materials (the “Notice”) because the Board of Directors (the “Board”) of Spruce Biosciences, Inc. (sometimes referred to as “we,” “us,” “our,” or the “Company”) is soliciting your proxy to vote at the 2024 Annual Meeting of Stockholders (the “Annual Meeting”), including at any adjournments or postponements of the Annual Meeting. All stockholders will have the ability to access the proxy materials on the website referred to in the Notice or request to receive a printed set of the proxy materials. Instructions on how to access the proxy materials over the internet or to request a printed copy may be found in the Notice. We intend to first mail the Notice and make this proxy statement and the form of proxy available on or about April 5, 2024 to all stockholders of record entitled to vote at the Annual Meeting. Will I receive any other proxy materials by mail? We may send you a proxy card, along with a second Notice, ten calendar days after our first mailing of the Notice or thereafter. Why are you holding a virtual Annual Meeting? The Annual Meeting will be held through a live webcast at www.virtualsha